Why the study?
Are serum levels of IGF-I and IGFBP-3 altered in obese children compared to non-obese healthy children?
Are serum levels of IGF-I and IGFBP-3 altered in obese children compared to non-obese healthy children?
Childhood obesity is associated with elevated serum IGF-I levels that correlate positively with body mass index.
Obesity-linked IGF-I elevation warrants no clinical practice change; leaves open longitudinal studies on causality and metabolic outcomes.
Growth hormone (GH) and insulin-like growth factor-I (IGF-I) metabolism may be disturbed in obese children. We investigated serum GH, IGF-I, IGF-binding protein-3 (IGFBP-3) levels in 42 obese and 40 non-obese healthy children aged 6-14 years. GH stimulation tests with L-dopa and insulin were performed. Serum IGF-I levels were studied by immunoradiometric assay (IRMA) and IGFBP-3 levels by radioimmunoassay (RIA). IGF-I levels were significantly higher in the obese group (p < 0.05), but IGFBP-3 levels were not different from the control group. IGF-I and IGFBP-3 levels were significantly higher in the obese pubertal children than in the obese prepubertal ones (p < 0.05). A positive linear correlation was found between body mass index (BMI) and IGF-I levels (r = 0.51, p < 0.05). These results suggest that obesity may have a considerable effect on IGF-I.
No takes yet. Share an insight, caveat, or question.
Bıdecı et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: